Obesity & Diabetes Portfolio
With medical editors MD, PhD in endocrinology, cardiology, and technology team, we design and implement impactful communication solutions for Medical Affairs, Market Access/HEOR, Launch Excellence, — supporting GLP-1, combination therapy, and related programs in obesity, type 2 diabetes, cardiometabolic risk, OSA, and MASH.
Type 2 Diabetes (T2D) Screening: Regional Early-Detection Strategy
Challenge: Build a practical early-screening plan for T2D, win support from health authorities and KOLs, and take it all the way through real-world execution.
We aligned experts and regulators around one model, trained frontline teams, set up logistics with labs, integrated forms and referrals into existing IT systems, and launched patient/HCP communications.
Economic Burden of Diabetes: Nationwide Cost-of-Illness & Policy Enablement
Challenge: To evaluate the economic burden of diabetes across the national healthcare system and guide local policy and reimbursement decisions.
Design and Development of a National Epidemiological Study Protocol
Challenge: Create a rigorous, ethics-ready protocol for a nationwide epidemiological study—built to deliver reliable, policy-relevant evidence on disease burden, care pathways, and outcomes.
Long-term Registry Analysis of SGLT2 Inhibitors
Challenge: Demonstrate long-term outcomes of SGLT2 inhibitors in real-world practice.
Systematic Review and Meta-analysis on SGLT2 Inhibitors
Challenge: Bring together fragmented evidence on efficacy and safety across multiple trials.
Cardiology Educational Program & Medical Content Support
Challenge: Development of a tailored educational program for cardiologists reframing the traditional obesity-first narrative into a CVD-centered approach — addressing obesity through the lens of cardiovascular risk.
- Unbranded scientific module on cardiovascular and metabolic links.
- Branded module based on validated semaglutide data.
Development, and Delivery of an HCP Speaker Training Program
Challenge: Prepare expert speakers for scientific sessions ahead of a product launch.One-day interactive workshop (15–30 cardiologists and endocrinologists) designed to enhance speaker capabilities and ensure alignment with the approved scientific and communication strategy.
Scientific Support a Regional Launch Conference
Challenge: Regional launch event aimed at aligning medical experts and stakeholders on the clinical and strategic positioning of GLP-1 therapy in cardiometabolic care.
Interactive Decision-Tree Cases
Challenge: Clearly show how clinicians choose a therapy in real life — who, when, and why — and highlight where the client’s treatment delivers the best value across lines of care and patient profiles.
Real-world logic: comorbidities, labs, prior lines, contraindications, payer rules.
Evidence on tap: each decision node links to trial data/RWE/Guidelines; claims and references are MLR-ready.
Multiple journeys: alternative branches (watchful waiting, switch, add-on, dose adjust) with outcomes and trade-offs.
Teaching modes: self-paced training, live session with ARS polling, and quick “5-minute case” for reps/MSL.
Omnichannel delivery: web & tablet, CLM/LMS integration, exportable slides/handouts; localization for markets.
Analytics: heatmaps of choices, time-on-task, common errors → targeted follow-ups and content updates.
Clinical Guidelines for Type 1 Diabetes
Challenge: Adapt international guidelines to local healthcare realities.